Follow the people · Insider
Christopher M. Hall
Christopher M. Hall files insider transactions with the SEC as a chief executive officer of Personalis (PSNL). We hold 4 disclosed purchases and sales filed since 14 August 2009, 2 of them in the last 90 days.
- Files forPSNL
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure9 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 March 2023 — 9 July 2026Chief Executive Officer · Personalis (PSNL)25 Form 4 lines · source: SEC Form 4
- Filed 19 February 2014 — 3 June 2019President and COO · Veracyte (VCYT)81 Form 4 lines · source: SEC Form 4
- Filed 12 August 2009 — 12 August 2009Chief Business Officer · Celera (CRA)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
110 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 100,000 shares of PersonalisSEC Form 49 July 2026Common Stock · traded 9 July 2026 · filed 9 July 2026
- ▼ sold on the open market 100,000 shares of PersonalisSEC Form 49 July 2026Common Stock · traded 9 July 2026 · filed 9 July 2026
- exercised options over 66,667 shares of Personalis (a derivative holding)SEC Form 49 July 2026Stock Option (right to buy) · traded 9 July 2026 · filed 9 July 2026
- exercised options over 33,333 shares of Personalis (a derivative holding)SEC Form 49 July 2026Stock Option (right to buy) · traded 9 July 2026 · filed 9 July 2026
- exercised options over 100,000 shares of PersonalisSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 100,000 shares of PersonalisSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- exercised options over 100,000 shares of Personalis (a derivative holding)SEC Form 426 June 2026Stock Option (right to buy) · traded 26 June 2026 · filed 26 June 2026
- exercised options over 19,909 shares of PersonalisSEC Form 429 May 2026Common Stock · traded 28 May 2026 · filed 29 May 2026
- ▼ sold on the open market 19,909 shares of PersonalisSEC Form 429 May 2026Common Stock · traded 28 May 2026 · filed 29 May 2026
- exercised options over 80,091 shares of PersonalisSEC Form 429 May 2026Common Stock · traded 29 May 2026 · filed 29 May 2026
- ▼ sold on the open market 80,091 shares of PersonalisSEC Form 429 May 2026Common Stock · traded 29 May 2026 · filed 29 May 2026
- exercised options over 19,909 shares of Personalis (a derivative holding)SEC Form 429 May 2026Stock Option (right to buy) · traded 28 May 2026 · filed 29 May 2026
- exercised options over 80,091 shares of Personalis (a derivative holding)SEC Form 429 May 2026Stock Option (right to buy) · traded 29 May 2026 · filed 29 May 2026
- was granted 87,500 shares of PersonalisSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 525,000 shares of Personalis (a derivative holding)SEC Form 417 March 2026Stock Option (right to buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 525,000 shares of Personalis (a derivative holding)SEC Form 417 March 2026Stock Option (right to buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 87,500 shares of PersonalisSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 33,333 shares of Personalis (a derivative holding)SEC Form 425 February 2026Stock Option (right to buy) · traded 23 February 2026 · filed 25 February 2026
- was granted 33,333 shares of Personalis (a derivative holding)SEC Form 425 February 2026Stock Option (right to buy) · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 29,612 shares of PersonalisSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- was granted 680,000 shares of Personalis (a derivative holding)SEC Form 418 March 2025Stock Option (right to buy) · traded 15 March 2025 · filed 18 March 2025
- ▼ sold on the open market 26,443 shares of PersonalisSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- was granted 400,000 shares of Personalis (a derivative holding)SEC Form 419 March 2024Stock Option (right to buy) · traded 15 March 2024 · filed 19 March 2024
- ▼ sold on the open market 20,459 shares of PersonalisSEC Form 43 November 2023Common Stock · traded 1 November 2023 · filed 3 November 2023
- was granted 400,000 shares of Personalis (a derivative holding)SEC Form 417 March 2023Stock Option (right to buy) · traded 15 March 2023 · filed 17 March 2023
- had shares withheld for tax on 456 shares of VeracyteSEC Form 45 June 2019Common Stock · traded 3 June 2019 · filed 5 June 2019
- exercised options over 42,748 shares of Veracyte (a derivative holding)SEC Form 48 May 2019Stock Option (right to buy) · traded 6 May 2019 · filed 8 May 2019
- exercised options over 63,746 shares of Veracyte (a derivative holding)SEC Form 48 May 2019Stock Option (right to buy) · traded 6 May 2019 · filed 8 May 2019
- exercised options over 8,506 shares of Veracyte (a derivative holding)SEC Form 48 May 2019Stock Option (right to buy) · traded 6 May 2019 · filed 8 May 2019
- exercised options over 42,748 shares of VeracyteSEC Form 48 May 2019Common Stock · traded 6 May 2019 · filed 8 May 2019
- exercised options over 63,746 shares of VeracyteSEC Form 48 May 2019Common Stock · traded 6 May 2019 · filed 8 May 2019
- exercised options over 8,506 shares of VeracyteSEC Form 48 May 2019Common Stock · traded 6 May 2019 · filed 8 May 2019
- ▼ sold on the open market 28,780 shares of VeracyteSEC Form 48 May 2019Common Stock · traded 6 May 2019 · filed 8 May 2019
- ▼ sold on the open market 86,220 shares of VeracyteSEC Form 48 May 2019Common Stock · traded 6 May 2019 · filed 8 May 2019
- exercised options over 17,927 shares of Veracyte (a derivative holding)SEC Form 412 April 2019Stock Option (right to buy) · traded 11 April 2019 · filed 12 April 2019
- exercised options over 43,017 shares of Veracyte (a derivative holding)SEC Form 412 April 2019Stock Option (right to buy) · traded 11 April 2019 · filed 12 April 2019
- exercised options over 19,056 shares of Veracyte (a derivative holding)SEC Form 412 April 2019Stock Option (right to buy) · traded 11 April 2019 · filed 12 April 2019
- exercised options over 17,927 shares of VeracyteSEC Form 412 April 2019Common Stock · traded 11 April 2019 · filed 12 April 2019
- exercised options over 43,017 shares of VeracyteSEC Form 412 April 2019Common Stock · traded 11 April 2019 · filed 12 April 2019
- exercised options over 19,056 shares of VeracyteSEC Form 412 April 2019Common Stock · traded 11 April 2019 · filed 12 April 2019
- ▼ sold on the open market 75,164 shares of VeracyteSEC Form 412 April 2019Common Stock · traded 11 April 2019 · filed 12 April 2019
- ▼ sold on the open market 4,836 shares of VeracyteSEC Form 412 April 2019Common Stock · traded 11 April 2019 · filed 12 April 2019
- had shares withheld for tax on 1,459 shares of VeracyteSEC Form 44 March 2019Common Stock · traded 2 March 2019 · filed 4 March 2019
- had shares withheld for tax on 2,282 shares of VeracyteSEC Form 44 March 2019Common Stock · traded 3 March 2019 · filed 4 March 2019
- exercised options over 3,500 shares of Veracyte (a derivative holding)SEC Form 41 November 2018Stock Option (right to buy) · traded 31 October 2018 · filed 1 November 2018
- exercised options over 16,927 shares of Veracyte (a derivative holding)SEC Form 41 November 2018Stock Option (right to buy) · traded 31 October 2018 · filed 1 November 2018
- exercised options over 19,573 shares of Veracyte (a derivative holding)SEC Form 41 November 2018Stock Option (right to buy) · traded 31 October 2018 · filed 1 November 2018
- exercised options over 3,500 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- ▼ sold on the open market 3,500 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- exercised options over 16,927 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- ▼ sold on the open market 16,500 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- ▼ sold on the open market 427 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- exercised options over 19,573 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- ▼ sold on the open market 19,573 shares of VeracyteSEC Form 41 November 2018Common Stock · traded 31 October 2018 · filed 1 November 2018
- exercised options over 4,237 shares of Veracyte (a derivative holding)SEC Form 410 August 2018Stock Option (right to buy) · traded 9 August 2018 · filed 10 August 2018
- exercised options over 8,263 shares of Veracyte (a derivative holding)SEC Form 410 August 2018Stock Option (right to buy) · traded 9 August 2018 · filed 10 August 2018
- exercised options over 7,500 shares of Veracyte (a derivative holding)SEC Form 410 August 2018Stock Option (right to buy) · traded 9 August 2018 · filed 10 August 2018
- exercised options over 4,237 shares of VeracyteSEC Form 410 August 2018Common Stock · traded 9 August 2018 · filed 10 August 2018
- exercised options over 8,263 shares of VeracyteSEC Form 410 August 2018Common Stock · traded 9 August 2018 · filed 10 August 2018
- exercised options over 7,500 shares of VeracyteSEC Form 410 August 2018Common Stock · traded 9 August 2018 · filed 10 August 2018
- ▼ sold on the open market 20,000 shares of VeracyteSEC Form 410 August 2018Common Stock · traded 9 August 2018 · filed 10 August 2018
- exercised options over 10,000 shares of VeracyteSEC Form 424 July 2018Common Stock · traded 24 July 2018 · filed 24 July 2018
- ▼ sold on the open market 10,000 shares of VeracyteSEC Form 424 July 2018Common Stock · traded 24 July 2018 · filed 24 July 2018
- exercised options over 10,000 shares of Veracyte (a derivative holding)SEC Form 424 July 2018Stock Option (right to buy) · traded 24 July 2018 · filed 24 July 2018
- exercised options over 17,570 shares of VeracyteSEC Form 49 July 2018Common Stock · traded 5 July 2018 · filed 9 July 2018
- ▼ sold on the open market 17,570 shares of VeracyteSEC Form 49 July 2018Common Stock · traded 5 July 2018 · filed 9 July 2018
- exercised options over 32,430 shares of VeracyteSEC Form 49 July 2018Common Stock · traded 6 July 2018 · filed 9 July 2018
- ▼ sold on the open market 32,430 shares of VeracyteSEC Form 49 July 2018Common Stock · traded 6 July 2018 · filed 9 July 2018
- exercised options over 17,570 shares of Veracyte (a derivative holding)SEC Form 49 July 2018Stock Option (right to buy) · traded 5 July 2018 · filed 9 July 2018
- exercised options over 32,430 shares of Veracyte (a derivative holding)SEC Form 49 July 2018Stock Option (right to buy) · traded 6 July 2018 · filed 9 July 2018
- exercised options over 10,509 shares of VeracyteSEC Form 419 June 2018Common Stock · traded 15 June 2018 · filed 19 June 2018
- ▼ sold on the open market 10,509 shares of VeracyteSEC Form 419 June 2018Common Stock · traded 15 June 2018 · filed 19 June 2018
- exercised options over 9,491 shares of VeracyteSEC Form 419 June 2018Common Stock · traded 19 June 2018 · filed 19 June 2018
- ▼ sold on the open market 9,491 shares of VeracyteSEC Form 419 June 2018Common Stock · traded 19 June 2018 · filed 19 June 2018
- exercised options over 10,509 shares of Veracyte (a derivative holding)SEC Form 419 June 2018Stock Option (right to buy) · traded 15 June 2018 · filed 19 June 2018
- exercised options over 9,491 shares of Veracyte (a derivative holding)SEC Form 419 June 2018Stock Option (right to buy) · traded 19 June 2018 · filed 19 June 2018
- was granted 110,250 shares of Veracyte (a derivative holding)SEC Form 45 March 2018Stock Option (right to buy) · traded 2 March 2018 · filed 5 March 2018
- was granted 14,700 shares of VeracyteSEC Form 45 March 2018Common Stock · traded 2 March 2018 · filed 5 March 2018
- had shares withheld for tax on 2,245 shares of VeracyteSEC Form 45 March 2018Common Stock · traded 3 March 2018 · filed 5 March 2018
- exercised options over 20,000 shares of VeracyteSEC Form 44 October 2017Common Stock · traded 2 October 2017 · filed 4 October 2017
- ▼ sold on the open market 20,000 shares of VeracyteSEC Form 44 October 2017Common Stock · traded 2 October 2017 · filed 4 October 2017
- exercised options over 20,000 shares of Veracyte (a derivative holding)SEC Form 44 October 2017Stock Option (right to buy) · traded 2 October 2017 · filed 4 October 2017
- was granted 20,000 shares of VeracyteSEC Form 46 March 2017Common Stock · traded 3 March 2017 · filed 6 March 2017
- was granted 80,000 shares of Veracyte (a derivative holding)SEC Form 46 March 2017Stock Option (right to buy) · traded 3 March 2017 · filed 6 March 2017
- was granted 85,000 shares of Veracyte (a derivative holding)SEC Form 43 March 2016Stock option (right to buy) · traded 1 March 2016 · filed 3 March 2016
- exercised options over 2,500 shares of VeracyteSEC Form 423 July 2015Common Stock · traded 22 July 2015 · filed 23 July 2015
- ▼ sold on the open market 2,500 shares of VeracyteSEC Form 423 July 2015Common Stock · traded 22 July 2015 · filed 23 July 2015
- exercised options over 2,500 shares of Veracyte (a derivative holding)SEC Form 423 July 2015Employee Stock Option (right to buy) · traded 22 July 2015 · filed 23 July 2015
- was granted 80,000 shares of Veracyte (a derivative holding)SEC Form 45 March 2015Stock Option (right to buy) · traded 2 March 2015 · filed 5 March 2015
- was granted 40,000 shares of Veracyte (a derivative holding)SEC Form 417 September 2014Stock Option (right to buy) · traded 16 September 2014 · filed 17 September 2014
- exercised options over 1,000 shares of VeracyteSEC Form 412 September 2014Common Stock · traded 10 September 2014 · filed 12 September 2014
- ▼ sold on the open market 1,000 shares of VeracyteSEC Form 412 September 2014Common Stock · traded 10 September 2014 · filed 12 September 2014
- exercised options over 1,000 shares of Veracyte (a derivative holding)SEC Form 412 September 2014Employee Stock Option (right to buy) · traded 10 September 2014 · filed 12 September 2014
- exercised options over 1,000 shares of VeracyteSEC Form 420 August 2014Common Stock · traded 18 August 2014 · filed 20 August 2014
- ▼ sold on the open market 1,000 shares of VeracyteSEC Form 420 August 2014Common Stock · traded 18 August 2014 · filed 20 August 2014
- exercised options over 1,000 shares of Veracyte (a derivative holding)SEC Form 420 August 2014Employee Stock Option (right to buy) · traded 18 August 2014 · filed 20 August 2014
- exercised options over 3,000 shares of VeracyteSEC Form 411 July 2014Common Stock · traded 10 July 2014 · filed 11 July 2014
- ▼ sold on the open market 3,000 shares of VeracyteSEC Form 411 July 2014Common Stock · traded 10 July 2014 · filed 11 July 2014
- exercised options over 3,000 shares of Veracyte (a derivative holding)SEC Form 411 July 2014Employee Stock Option (right to buy) · traded 10 July 2014 · filed 11 July 2014
- exercised options over 2,000 shares of VeracyteSEC Form 423 June 2014Common Stock · traded 23 June 2014 · filed 23 June 2014
- ▼ sold on the open market 2,000 shares of VeracyteSEC Form 423 June 2014Common Stock · traded 23 June 2014 · filed 23 June 2014
- exercised options over 2,000 shares of Veracyte (a derivative holding)SEC Form 423 June 2014Employee Stock Option (right to buy) · traded 23 June 2014 · filed 23 June 2014
- exercised options over 3,000 shares of VeracyteSEC Form 420 June 2014Common Stock · traded 19 June 2014 · filed 20 June 2014
- ▼ sold on the open market 3,000 shares of VeracyteSEC Form 420 June 2014Common Stock · traded 19 June 2014 · filed 20 June 2014
- exercised options over 3,000 shares of Veracyte (a derivative holding)SEC Form 420 June 2014Employee Stock Option (right to buy) · traded 19 June 2014 · filed 20 June 2014
- was granted 70,000 shares of Veracyte (a derivative holding)SEC Form 421 February 2014Stock option (right to buy) · traded 19 February 2014 · filed 21 February 2014
- was granted 24,000 shares of Celera (a derivative holding)SEC Form 414 August 2009Stock Option (Right to Buy) · traded 12 August 2009 · filed 14 August 2009
- was granted 8,000 shares of CeleraSEC Form 414 August 2009Common Stock · traded 12 August 2009 · filed 14 August 2009
- returned to the issuer 9,290 shares of CeleraSEC Form 414 August 2009Common Stock · traded 12 August 2009 · filed 14 August 2009
- had shares withheld for tax on 2,638 shares of CeleraSEC Form 414 August 2009Common Stock · traded 12 August 2009 · filed 14 August 2009
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.